The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis

Calcified Tissue International - Tập 38 - Trang 318-322 - 1986
Bente Juel Riis1,2, Paul Rødbro1,2, Claus Christiansen1,2
1Department of Clinical Chemistry, Glostrup Hospital, Glostrup, Denmark
2Department of Clinical Physiology, Aalborg Hospital, Denmark

Tóm tắt

It has been debated whether postmenopausal osteoporosis is characterized by high or low bone turnover and whether circulating levels of sex steroids contribute to the occurrence of osteoporotic fractures. We examined 154 70-year-old women with or without osteoporotic fractures, and 178 early postmenopausal women with a “rapid” or a “slow” bone loss. In all participants, we determined markers of bone formation (serum alkaline phosphatase (AP) and serum bone Gla protein (BGP)), markers of bone resorption (fasting urinary calcium/creatinine (FU Ca/Cr) and hydroxyproline/creatinine (FU Hpr/Cr)), and serum estrone (E1), estradiol (E2), androstenedione (A), and fat mass. The 70-year-old womenwith osteoporotic fractures had significantly elevated AP (P<0.001), BGP (P<0.001), and FU Hpr/Cr (P<0.001) compared with the groupwithout fractures. In the group of early postmenopausal women, the “rapid” bone losers had significantly increased FU Hpr/Cr (P<0.001) and FU Ca/Cr (P<0.001). E1, E2, A, and the fat mass did not differ in the groups with and without osteoporotic fractures, whereas the “rapid” bone losers had significantly lower E1 (P<0.05), E2 (P<0.05), and fat mass (P<0.01) than the ‘slow” bone losers. It is concluded that patients with manifest osteoporosis and early postmenopausal women with a rapid bone loss have increased biochemical markers of bone turnover. Moreover, the present study demonstrates that early postmenopausal women with an “excessive” bone loss have significantly decreased serum estrogens, whereas it is not possible to detect low estrogens in women with osteoporotic fractures.

Tài liệu tham khảo

Mazess RB (1982) On aging bone loss. Clin Orthop 165:239–552 Christiansen C, Rødbro P (1984) Serum vitamin D metabolites in younger and elderly postmenopausal women. Calcif Tissue Int 36:19–24 Jensen GF, Christiansen C, Boesen J, Hegedüs V, Transbøl I (1982) Epidemiology of postmenopausal spinal and long bone fractures. Clin Orthop 166:75–81 Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I (1980) Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273–279 Johnston Jr CC, Norton Jr JA, Khairi RA, Longcope C (1979) Age-related bone loss. In: Barzil US (ed) Osteoporosis II. Grune & Stratton, New York, pp 91–100 Marshall DH, Crilly RG, Nordin BEC (1977) Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women, Br Med J 2:1177–1179 Davidson BJ, Riggs BL, Wahner HW, Judd HL (1983) Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures. Obst Gynecol 61:275–278 Nordin BEC (1978) Diagnostic procedures in disorders of calcium metabolism. Clin Endocrinol (Oxf) 8:55–67 Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas, HG (1977) Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 26:589–606 Brown JP, Malavel L, Chapuy MC, Delmas PD, Edouard C, Meunier PJ (1984) Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet i:1091–1093 Nordin BEC, Peacock M, Aaron J, Crilly RG, Heyburn PJ, Horsman A, Marshall D (1980) Osteoporosis and osteomalacia. Clin Endocrinol Metab 9:177–203 Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL (1983) Increase in serum bone γ-carboxyglutamic acid and protein with aging in women. J Clin Invest 71:1316–1321 Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL (1982) Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med 72:193–202 Meunier PJ, Courpron P, Edouard C, Alexandre C, Bressot C, Lips P, Boyce BF (1979) Bone histomorphometry in osteoporotic states. In: Barzell US (ed) Osteoporosis II. Grune & Stratton, New York, pp 27–47 Darby AJ, Meunier PJ (1981) Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis. Calcif Tissue Int 33:199–204 Catherwood BD, Marcus R, Madvis P, Cheung AD (1982) Region specific radioimmunoassay (RIA) for human bone gamma-carboxyglutamic acid-containing protein (BGP) in blood of normal subjects. Calcif Tissue Int (Suppl) 34:29 Pødenphant J, Larsen N-E, Christiansen C (1984) An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 142:145–148 Jensen J, Riis BJ, Hummer L, Christiansen C (1985) The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause. Br J Obstet Gynaecol 92:260–265 Hummer L, Nielsen MD, Christiansen C (1983) An easy and reliable radioimmunoassay of serum androstenedione: age-related normal values in 252 females aged 2 to 70 years. Scand J Clin Lab Invest 43:301–306 Christiansen C, Rødbro P, Jensen H (1975) Bone mineral content in the forearm measured by photon absorptiometry. Scand J Clin Lab Invest 35:323–330 Gotfredsen A, Borg J, Christiansen C (1983) In vivo estimation of total body bone mineral by dual photon absorptiometry. Precision and accuracy. J Comput Assist Tomogr 7:550–551 Boddy K, King PC, Hume R, Weyers E (1972) The relation of total body potassium to height, weight and age in normal adults. J Clin Pathol 25:512–517 Crilly RG, Marshall DH, Nordin BEC (1979) Effect of age on plasma androstenedione concentration in oophorectomized women. Clin Endocrinol 10:199–201 Nilsson BE, Westlin NE (1972) The plasma concentration of alkaline phosphatase, phosphorus and calcium following femoral neck fracture. Acta Orthop Scand 43:504–510 Soules MR, Bremner WJ (1982) The menopause and climacteric: endocrinologic basis and associated symptomatology. J Am Geriatr Soc 30:547–561 Parfitt AM (1982) Treatment of osteoporosis: theoretical possibilities. Clin Invest Med 5:181–183